EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients

Ya-Chu Kuo, Hsuan-Yu Huang, Hsuan-Hui Ho, Li-Jiuan Shen, Ching-Hua Kuo

Analytical and Bioanalytical Chemistry · 2026-11 · 418 (22) · 7339-7352

DOI: 10.1007/s00216-026-06728-3 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 18.08.2026. Verfasst von Ya-Chu Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. Hauptthemen laut MEDLINE: Tamoxifen, Breast Neoplasms, Tandem Mass Spectrometry, Liquid Chromatography-Mass Spectrometry. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tamoxifen requires biotransformation into metabolites to exert antiestrogenic activity, and variability in metabolite exposure contributes to interindividual differences in clinical outcomes. Volumetric absorptive microsampling (VAMS) provides a convenient and minimally invasive alternative for therapeutic drug monitoring (TDM). However, analytical methods enabling comprehensive quantification of tamoxifen and its metabolites in VAMS remain limited, and translation of VAMS-derived concentrations into plasma-equivalent values has not been well established. In this study, an LC-MS/MS method was developed and fully validated for simultaneous quantification of tamoxifen and six metabolites in VAMS samples. Water prerinsing prior to methanol extraction improved analyte recoveries to 89.2-111.2%. Stability evaluation of VAMS samples revealed poor room-temperature stability for most analytes, whereas all analytes remained stable for at least 100 days at -80 °C. Experimentally derived plasma-to-blood concentration ratios (Cp/Cb, 1.41-1.83) were further applied to estimate plasma-equivalent concentrations from VAMS samples. Clinical applicability was evaluated using paired VAMS and plasma samples collected from ten tamoxifen-treated breast cancer patients. Strong correlations between VAMS-derived and measured plasma concentrations were observed (R2 = 0.77-0.98). Bland-Altman analysis further demonstrated good agreement, with more than 90% of values falling within the ±1.96 SD limits. These results demonstrate that the proposed workflow provides a reliable approach for comprehensive tamoxifen metabolite quantification in VAMS samples and supports plasma-equivalent concentration estimation for comparison with existing plasma-based therapeutic data. The proposed strategy may facilitate the clinical implementation of VAMS-based TDM for personalized tamoxifen therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenBreast NeoplasmsTandem Mass SpectrometryLiquid Chromatography-Mass SpectrometryAntineoplastic Agents, HormonalHumansFemaleDrug MonitoringChromatography, LiquidReproducibility of ResultsLimit of Detection

Stichwörter der Autor:innen

LC–MS/MSMetabolitesPlasma-to-blood concentration ratioTamoxifenTherapeutic drug monitoringVolumetric absorptive microsampling

Substanzen

TamoxifenAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan.
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. ljshen@ntu.edu.tw.
  • Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. ljshen@ntu.edu.tw.
  • Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan. ljshen@ntu.edu.tw.
  • School of Pharmacy, College of Medicine, National Taiwan University, No. 33, Linsen S. Rd., Chongsheng Dist., Taipei City , 100, Taiwan. kuoch@ntu.edu.tw.

Förderung

  • National Science and Technology Council, Taiwan

Zitieren

APA

Kuo, Y. C., Huang, H. Y., Ho, H. H., Shen, L. J., & Kuo, C. H. (2026). Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients. Analytical and Bioanalytical Chemistry, 418(22), 7339-7352. https://doi.org/10.1007/s00216-026-06728-3

Vancouver

Kuo YC, Huang HY, Ho HH, Shen LJ, Kuo CH. Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients. Analytical and Bioanalytical Chemistry. 2026;418(22):7339-7352. doi:10.1007/s00216-026-06728-3

BibTeX
@article{Kuo2026,
  author = {Kuo, Ya-Chu and Huang, Hsuan-Yu and Ho, Hsuan-Hui and Shen, Li-Jiuan and Kuo, Ching-Hua},
  title = {Development and validation of an LC–MS/MS method for the comprehensive quantification of tamoxifen and its metabolites in volumetric absorptive microsampling: clinical application in breast cancer patients},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  volume = {418},
  number = {22},
  pages = {7339--7352},
  doi = {10.1007/s00216-026-06728-3}
}
Kostenlos starten →